PMC:7647877 / 19335-19651
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T269 | 18-32 | Body_part | denotes | adipose tissue | http://purl.org/sig/ont/fma/fma20110 |
| T270 | 57-66 | Body_part | denotes | adipocyte | http://purl.org/sig/ont/fma/fma63880 |
| T271 | 189-198 | Body_part | denotes | cytokines | http://purl.org/sig/ont/fma/fma84050 |
| T272 | 204-213 | Body_part | denotes | adipocyte | http://purl.org/sig/ont/fma/fma63880 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T57 | 18-32 | Body_part | denotes | adipose tissue | http://purl.obolibrary.org/obo/UBERON_0001013 |
| T58 | 26-32 | Body_part | denotes | tissue | http://purl.obolibrary.org/obo/UBERON_0000479 |
| T59 | 83-95 | Body_part | denotes | visceral fat | http://purl.obolibrary.org/obo/UBERON_0035818 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T121 | 291-310 | Disease | denotes | metabolic disorders | http://purl.obolibrary.org/obo/MONDO_0005066 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T284 | 18-32 | http://purl.obolibrary.org/obo/UBERON_0001013 | denotes | adipose tissue |
| T285 | 57-66 | http://purl.obolibrary.org/obo/CL_0000136 | denotes | adipocyte |
| T286 | 92-95 | http://purl.obolibrary.org/obo/UBERON_0001013 | denotes | fat |
| T287 | 204-213 | http://purl.obolibrary.org/obo/CL_0000136 | denotes | adipocyte |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T38 | 57-78 | Phenotype | denotes | adipocyte hypertrophy | http://purl.obolibrary.org/obo/HP_0030759 |
| T39 | 177-185 | Phenotype | denotes | plethora | http://purl.obolibrary.org/obo/HP_0001050 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T120 | 0-316 | Sentence | denotes | The disruption of adipose tissue processes, as occurs in adipocyte hypertrophy and visceral fat accumulation, results in the production of pro-inflammatory components (like the plethora of cytokines) and adipocyte factors dysregulation, which may be both genesis and/or main contributors to metabolic disorders [39]. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 568 | 67-78 | Disease | denotes | hypertrophy | MESH:D006984 |
| 569 | 291-310 | Disease | denotes | metabolic disorders | MESH:D008659 |